Polyclonal Antibody to Homo sapiens (Human) Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1
- 100ug (PW018Hu01) US$ 316
Description: Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
Source:Polyclonal antibody preparation
Host: Rabbit
Reactivity: Homo sapiens (Human)
Isotype: IgG
Purification: Antigen-specific affinity chromatography
Label: None
Buffer Formulation: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Form Supplied: Liquid
Concentration: 200ug/ml
Tested Applications:
- Western blot (1:100 to 1:500)
- Immunofluorescence (1:50 to 1:400)
- Immunohistochemistry (1:200 to 1:500)
- Flow cytometry analysis (1:200 to 1:500)
- Enzyme-linked Immunosorbent Assay (1:100-1:5000)
Specifity: The antibody is a rabbit Polyclonal antibody raised against CDKN2A. It has been selected for its ability to recognize CDKN2A in immunohistochemical staining and western blotting.
Sample: Recombinant Human CDKN2A
Anti-Human CDKN2A antibody was used at 1:400 dilution.
Immunohistochemical staining:
DAB staining on IHC-P Samples:Tissue.
Stability: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Storage: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.